Skip to main content

Table 1 Clinical characteristics regarding 18 patients of 36 CMLNs treated with implantation of 125I-seeds

From: Ultrasound-guided implantation of radioactive 125I seed in radioiodine refractory differentiated thyroid carcinoma

Parameter

Characteristics

Result

Sex of patients (n = 18)

M/F

11/7A

Age of patients (n = 18)

 

52.2 ± 20.8 (27–87) B

Subtypes of DTC (n = 18)

PTC/FTC

17/1 (94/6) C

No. of neck surgeries performed (n = 18)

< 3/≥3

16/2 (89/11) C

Cumulative dose of RAI-131 (n = 18)

< 600/≥600mci

14/4 (78/22) C

BRAFV600E mutation (n = 18)

P/N

17/1 (94/6) C

No. of CMLNs (n = 18)

1

9 (50) C

2

3 (17) C

≥3

6 (33) C

Sides of CMLNs (n = 36)

L/R

15/21 (42/58) D

Level of CMLNs (n = 36)

I

0 (0) D

II

6 (17) D

III

12 (33) D

IV

10 (28) D

V

1 (3) D

VI

7 (19) D

Largest diameter of CMLNs (n = 36) (mm)

 

14.0 (8.0, 22.5) E

Initial volume of nodule (n = 36) (mm3)

 

523 (148, 2010) E

  1. M male, F female, PTC papillary thyroid carcinoma, FTC follicular thyroid carcinoma, P positive, N negative, L left, R right
  2. A Number of patients
  3. B Mean ± standard deviation, with range in brackets
  4. C Number of patients, with percentage in brackets
  5. D Number of CMLNs, with percentage in brackets
  6. E Median, with P25 and P75 in brackets